SCHEMBL7165449

SCHEMBL7165449

C=CCC1C=CC=CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38655900 0.74
SCHEMBL241738 0.73
SCHEMBL38663786 0.72
SCHEMBL9113655 0.71
SCHEMBL4719864 0.70
SCHEMBL27558364 0.70
SCHEMBL3960083 0.69 GABRR1 (0.33)
SCHEMBL878810 0.69
SCHEMBL7407105 0.69
SCHEMBL6069541 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116515110-A Modified polybenzimidazole and preparation method thereof 佛山科学技术学院 2023-08-01 CN claimed
US-10894875-B2 Films and unit dose articles comprising aversive UV-protective agents, and uses and methods related thereto THE PROCTER & GAMBLE COMPANY (US) 2021-01-19 US claimed
US-20190185637-A1 FILMS AND UNIT DOSE ARTICLES COMPRISING AVERSIVE UV-PROTECTIVE AGENTS, AND USES AND METHODS RELATED THERETO THE PROCTER & GAMBLE COMPANY 2019-06-20 US claimed
EP-3498812-A1 FILMS AND UNIT DOSE ARTICLES COMPRISING AVERSIVE UV-PROTECTIVE AGENTS, AND USES AND METHODS RELATED THERETO The Procter & Gamble Company (US) 2019-06-19 EP claimed
JP-2158694-A None JP disclosed
CN-116515110-A Modified polybenzimidazole and preparation method thereof 佛山科学技术学院 2023-08-01 CN disclosed
US-10894875-B2 Films and unit dose articles comprising aversive UV-protective agents, and uses and methods related thereto THE PROCTER & GAMBLE COMPANY (US) 2021-01-19 US disclosed
CN-104000785-B Novel dosage forms of metaxalone 伊休蒂卡有限公司 2021-01-05 CN disclosed
US-20200115397-A1 FUNCTIONALIZED SILICON Nanostar Inc. (US) 2020-04-16 US disclosed
US-20200115237-A1 Mechanochemically Functionalized Silicon Nanostar Inc. (US) 2020-04-16 US disclosed
US-10434570-B1 Mechanochemical functionalization of silicon NANOSTAR, INC. (US) 2019-10-08 US disclosed
CN-110049989-A Light produces lewis acid agent 株式会社日本触媒 2019-07-23 CN disclosed
EP-3498812-A1 FILMS AND UNIT DOSE ARTICLES COMPRISING AVERSIVE UV-PROTECTIVE AGENTS, AND USES AND METHODS RELATED THERETO The Procter & Gamble Company (US) 2019-06-19 EP disclosed
CN-107287250-A The method for improving simultaneous saccharification and fermentation reaction efficiency 丹尼斯科美国公司 2017-10-24 CN disclosed
CN-104736245-B Polymeric and solid-supported catalysts, and methods of digesting cellulosic materials using such catalysts 米德瑞(美国)有限公司 2017-04-12 CN disclosed
CN-100471486-C Immunomodulatory compositions, methods of making, and methods of use thereof DYNAVAX TECH CORP (US) 2009-03-25 CN disclosed
CN-1674878-A Immunomodulatory compositions, methods of making, and methods of use thereof DYNAVAX TECH CORP (US) 2005-09-28 CN disclosed
EP-1303486-A1 PYRROLIDINE DERIVATIVES AS METALLOPROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2003-04-23 EP disclosed
WO-2002008185-A1 PYRROLIDINE DERIVATIVES AS METALLOPROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2002-01-31 WO disclosed
JP-H02158694-A PERFUMERY COMPOSITION T HASEGAWA CO LTD 1990-06-19 JP disclosed